Skip to main content

Millennials keen to trade blood and urine samples for premium discounts

A syringe is made ready for an injection

Millennials in the UK are prepared to give up their own blood, urine, and personal data if it means lowering their insurance premiums, according to a survey conducted by generation researchers Decode.

The study, conducted on behalf of business applications company Pegasystems and outsourcing provider Capgemini, surveyed 1,000 UK residents between the ages of 18 and 34 on their attitudes to

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: https://subscriptions.postonline.co.uk/subscribe

You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Post? View our subscription options

Q&A: Chris Sawford, Verisk

Chris Sawford, managing director of UK and Ireland general insurance at Verisk, explains why fraud prevention is becoming a strategic business priority, and considers the evolving fraud landscape and insurer challenges.

The changing face of insurance fraudsters

David Worsfold investigates how insurers face a growing challenge in distinguishing deliberate deception from opportunism, financial hardship and genuine customer vulnerability when it comes to insurance fraud.

Q&A: Nutan Rajguru, Verisk

Nutan Rajguru, head of analytics at Verisk, explains how data, analytics and artificial intelligence can help insurers identify risk earlier, generate stronger insights and make more informed decisions.

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here